Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 30 matching records.
30 results — page 1 of 2
- Level AMeta-analysisEurope PMC
Genetically modified stem cells for osteoporosis: a systematic review and meta-analysis of preclinical studies
Meta-analysis, published in BMC Musculoskelet Disord (2025) — summary generated from the PubMed abstract.
- 2025
BMC Musculoskelet Disord3 citations - Level DAnimal StudyPubMed
Functional Assessment of Genetically Modified Infrapatellar Fat Pad Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles (EVs): Potential Implications for Inflammation/Pain Reversal in Osteoarthritis.
Animal Study on Osteoarthritis, Cartilage Damage, Neuroinflammation, Chronic Inflammation, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
Cells - Level DAnimal StudyEurope PMC
Urine-derived stem cells genetically modified with IGF1 improve muscle regeneration
Animal Study, published in Am J Clin Exp Urol (2024) — summary generated from the PubMed abstract.
- 2024
Am J Clin Exp Urol4 citations - Level DNarrative ReviewEurope PMC
Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction
Narrative Review on Cardiovascular Disease, Scar, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther8 citations - Level ASystematic ReviewEurope PMC
Biologic Brachytherapy: Genetically Modified Surgical Flap as a Therapeutic Tool-A Systematic Review of Animal Studies
Systematic Review on Systemic / IV, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci - Level CProspective StudyPubMed
Netrin1-Enriched Exosomes From Genetically Modified ADSCs as a Novel Treatment for Diabetic Limb Ischemia.
Prospective Study on Systemic / IV, published in Adv Healthc Mater (2024) — summary generated from the PubMed abstract.
- 2024
Adv Healthc Mater6 citations - Level DAnimal StudyEurope PMC
Mesenchymal Stem Cells Genetically Modified by Lentivirus-Express Soluble TRAIL and Interleukin-12 Inhibit Growth and Reduced Metastasis-Relate Changes in Lymphoma Mice Model
Animal Study, published in Biomedicines (2023) — summary generated from the PubMed abstract.
- 2023
Biomedicines6 citations - Level DNarrative ReviewEurope PMC
Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases
Narrative Review, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther7 citations - Level DNarrative ReviewEurope PMC
The Beneficial Potential of Genetically Modified Stem Cells in the Treatment of Stroke: a Review
Narrative Review on Stroke Research, published in Stem Cell Rev Rep (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Rev Rep16 citations - Level DAnimal StudyPubMed
Genetically modified adipose-derived stem cells with matrix metalloproteinase 3 promote scarless cutaneous repair.
Animal Study on Chronic Wound, Scar, published in Dermatol Ther (2020) — summary generated from the PubMed abstract.
- 2020
Dermatol Ther7 citations - Level DNarrative ReviewEurope PMC
Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment
Narrative Review on Cardiovascular Disease, published in Int J Mol Sci (2020) — summary generated from the PubMed abstract.
- 2020
Int J Mol Sci43 citations - Level DLaboratory StudyEurope PMC
Literature review of baseline information on non‐coding RNA (ncRNA) to support the risk assessment of ncRNA‐based genetically modified plants for food and feed
Laboratory Study on Systemic / IV, published in EFSA Supporting Publications (2019) — summary generated from the PubMed abstract.
- 2019
EFSA Supporting Publications - Level DLaboratory StudyEurope PMC
Transplantation of HUVECs with genetically modified Nogo-B accelerates wound-healing in nude mice
Laboratory Study on Chronic Wound, published in Am J Transl Res (2019) — summary generated from the PubMed abstract.
- 2019
Am J Transl Res3 citations - Level DNarrative ReviewEurope PMC
Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
Narrative Review on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cell Res Ther36 citations - Level DAnimal StudyPubMed
Sustained release of TGF-β1 via genetically-modified cells induces the chondrogenic differentiation of mesenchymal stem cells encapsulated in alginate sulfate hydrogels.
Animal Study, published in J Mater Sci Mater Med (2018) — summary generated from the PubMed abstract.
- 2018
J Mater Sci Mater Med - Level DAnimal StudyPubMed
Telomerase reverse transcriptase genetically modified adipose tissue derived stem cells improves erectile dysfunction by inhibiting oxidative stress and enhancing proliferation in rat model.
Animal Study, published in Biomed Pharmacother (2017) — summary generated from the PubMed abstract.
- 2017
Biomed Pharmacother4 citations - Level BClinical TrialPubMed
Preclinical Biosafety Evaluation of Genetically Modified Human Adipose Tissue-Derived Mesenchymal Stem Cells for Clinical Applications to Brainstem Glioma.
Clinical Trial on Systemic / IV, published in Stem Cells Dev (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Dev - Level DAnimal StudyEurope PMC
Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase
Animal Study on Systemic / IV, published in Oncotarget (2016) — summary generated from the PubMed abstract.
- 2016
Oncotarget16 citations - Level DAnimal StudyPubMed
Metastatic Ovarian Cancer Can Be Efficiently Treated by Genetically Modified Mesenchymal Stromal Cells.
Animal Study, published in Stem Cells Dev (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Dev - Level DAnimal StudyPubMed
Implant Composed of Demineralized Bone and Mesenchymal Stem Cells Genetically Modified with AdBMP2/AdBMP7 for the Regeneration of Bone Fractures in Ovis aries .
Animal Study, published in Stem Cells Int (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Int11 citations - Level DAnimal StudyPubMed
Genetically modified murine adipose-derived mesenchymal stem cells producing interleukin-2 favor B16F10 melanoma cell proliferation.
Animal Study on Systemic / IV, published in Immunol Invest (2015) — summary generated from the PubMed abstract.
- 2015
Immunol Invest12 citations - Level DAnimal StudyPubMed
Intratunical Injection of Genetically Modified Adipose Tissue-Derived Stem Cells with Human Interferon α-2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis.
Animal Study, published in J Sex Med (2015) — summary generated from the PubMed abstract.
- 2015
J Sex Med37 citations - Level DNarrative ReviewPubMed
The potential role of genetically-modified pig mesenchymal stromal cells in xenotransplantation.
Narrative Review on Chronic Inflammation, Immune Modulation, published in Stem Cell Rev Rep (2014) — summary generated from the PubMed abstract.
- 2014
Stem Cell Rev Rep19 citations - Level CProspective StudyPubMed
Genetically modified adipose tissue-derived stem/stromal cells, using simian immunodeficiency virus-based lentiviral vectors, in the treatment of hemophilia B.
Prospective Study, published in Hum Gene Ther (2013) — summary generated from the PubMed abstract.
- 2013
Hum Gene Ther15 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406